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ABSTRACT
Objective: The main purpose of the present study was to analyze the antidiabetic activity of methanolic extract of the leaf of Kalanchoe pinnata in 
alloxan-induced diabetic rats.
Methods: Diabetes mellitus (DM) is a chronic metabolic and endocrine disease regarded as a serious global public health problem. Albino Wistar 
rats were divided into four groups. Group I (normal) received drinking water throughout the course till 20 days. Groups II-IV received alloxan 
(120 mg/kg b.w) i.p on the 1st day of the study period. Group III animals received glibenclamide (10 mg/kg p.o) and Group IV received K. pinnata 
(200 mg/kg b.w p.o) for 20 days. The body weight, blood glucose level, serum urea, blood urea nitrogen (BUN), creatinine, cholesterol, total protein 
(TP), uric acid, and tissue (liver) antioxidant parameters: Malondialdehyde (MDA) and glutathione (GSH) were measured.
Results: K. pinnata treated rats showed the percentage increase in the body weight, decrease in the blood sugar level, creatinine, TP level, urea, uric 
acid, and BUN, MDA, and GSH when compared to alloxan-induced diabetic mellitus control rats. Thus, K. pinnata could be possibly employed to treat DM.
Conclusion: This preliminary analysis tested the most promising profile. It seems that methanolic extract of the leaf of K. pinnata improved general, 
blood serum, and liver antidiabetic agent. However, further studies confirming its potential is certainly warranted.
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INTRODUCTION
Fast-growing socioeconomic development in the past 10 years has 
revealed a rise in the lifestyle disorders among which diabetes mellitus 
(DM) is growing rapidly and has turned out to be like an epidemic in 
many parts of the world. In 2015, DM and its associated complications 
affected 415 million people globally and resulted in 5 million deaths [1]. 
The effects of DM include long-term complications such as heart 
disease, stroke, dysfunction, and failure of various organs [15].
The World Health Organization (WHO) has estimated that diabetes will 
be one of the world’s leading causes of death and disability within the 
next quarter century [14]. The incidence of DM is markedly increased 
worldwide due to modern sedentary lifestyle with consumption of junk 
food. Carbohydrates are the major constituents of the human diet and 
play an important role in energy supply [11]. DM is a major complex 
chronic condition that is a major source of ill health worldwide. 
Cardiovascular diseases, neuropathy, nephropathy, and retinopathy 
are among the major risks that are associated with diabetes [16]. This 
metabolic disorder is characterized by hyperglycemia and disturbances 
in carbohydrate, protein, and fat metabolism. Excessive generation 
of free radicals on unsaturated fatty acids has been implicated in the 
pathogenesis of vascular diseases and leads to increased oxidative 
stress [12]. According to the WHO projections, the prevalence of 
diabetes is such as to increase to 35% by 2020. At present, there are 
over 150 million diabetics worldwide and this is likely to increase to 
300 million or more by the year 2025. Statistical projection of India 
suggests that it is speculated to have the highest number of diabetics 
in the world since the number of diabetics will rise from 15 million in 
1995 to 57 million in 2025. Reasons for this rise include an increase 
in sedentary lifestyle, consumption of energy-rich diet, obesity, and a 
higher life span [2]. The treatment of DM in clinical practice has been 
confined to the use of oral hypoglycemic agents and insulin; the former 
being reported being endowed with characteristic profiles of serious 
side effects [10]. Kalanchoe pinnata is a succulent perennial plant that 
grows 3–5 feet tall. It commonly known as “air plant,” it has tall hollow 
stems, fleshy dark green leaves that are distinctively scalloped and 
trimmed in red, and bell-like pendulous flowers. This is employed in folk 
medicine for the treatment of kidney stones, gastric ulcer, pulmonary 
infection, rheumatoid arthritis, etc. [3]. Alloxan is toxic glucose analogs 
that preferentially accumulate in pancreatic beta-cells through the 
GLUT2 glucose transporter. In the presence of intracellular thiols, 
especially glutathione (GSH), alloxan generates reactive oxygen species 
(ROS) in a cyclic redox reaction with its reduction product, dialuric acid. 
Autoxidation of dialuric acid generates superoxide radicals, hydrogen 
peroxide, and, in a final iron-catalyzed reaction step, hydroxyl radicals. 
These hydroxyl radicals are ultimately responsible for the death of the 
beta-cells [4]. In the present study, the methanolic extract of the leaves 




Male albino Wistar rats (180–200 g) were purchased from Adita 
Biosys Private Limited, Tumakuru-572106, CPCSEA Reg No - 1868/
Po/Bt/S/16/CPCEA and were maintained in the animals house of 
PES College of Pharmacy, Bengaluru. Once procured, animals were 
acclimatized for 10 days under standard husbandry conditions, the 
animals were housed in polypropylene cages maintained under 
controlled temperature at 23°C±2°C, relative humidity 45–55%, 
and with 12:12 h day/night cycle. Temperature and humidity were 
recorded daily. The animals had free access to standard rat pellet along 
with water supplied ad libitum under strict hygienic conditions. The 
experimental protocols were subjected to approval by the Institutional 
Animal Ethics Committee (IAEC approval No - PESCP/IAEC/63/2018 
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dated 13-1-2018 and conducted according to CPCSEA guidelines, 
Government of India).
Drugs and chemicals
Glibenclamide, tris-HCl, Ellman’s reagent, thiobarbituric acid, alloxan 
monohydrate, blood urea nitrogen (BUN), creatinine, urea, total 
cholesterol (TC), uric acid, total protein (TP), etc., were used. These 
drugs/chemicals/kits were procured from authentic suppliers in 
Bengaluru. All the other chemicals used in the study were of analytical 
grade and the highest purity.
Induction of DM in rats
After 18 h of fasting in rats, stable DM was induced to Groups II-IV 
rats by single intraperitoneal injection of alloxan (120 mg/kg ip) 
dissolved in normal saline and Group I rats (vehicle control) received 
only the normal saline. The rats were given the standard diet (20% 
glucose solution for 12 h to prevent initial drug-induced hypoglycemic 
mortality) and water ad libitum. After 72 h of alloxan injection, fasted 
blood glucose levels were estimated by the tail-tip method using 
glucometer. Only rats with the blood glucose level over 150 mg/dL were 
considered to be diabetic rats and were used for the experiment [5].
Pharmacological activities
The animals used for testing consisted of four groups. Group I (normal) 
received drinking water throughout the course till 20 days. Groups II-IV 
received alloxan (120 mg/kg b.w) i.p on the 1st day of the study period. 
Group III animals received from the 4th day glibenclamide (10 mg/kg p.o 
for the duration of 20 days. Group IV received from the 4th day K. pinnata 
(200 mg/kg b.w p.o) for the duration of 20 days. Fasted blood samples 
were collected from the tail vein for the blood glucose estimation of the 
0th, 10th, and 20th days using one touch glucometer. The food and water 
intake was monitored daily for each rat, and the periodical differences 
in the body weight of the individual animals were also measured during 
20 days of the experimental period.
Blood sampling and serum processing
Fasted blood samples were collected from the tail vein for the blood 
glucose estimation. The rats were anesthetized using light ketamine 
anesthesia at the dose of 40 mg/kg b.w i.p. 24 h after the final dosing 
schedule. Then, the blood was withdrawn using a capillary tube from 
the retro-orbital plexus. 1 ml of blood was collected from each animal 
of all the groups in Eppendorf tubes. The collected blood was kept in 
an upright position for 30–45 min incubation to facilitate clotting and 
then subjected to cold centrifugation at 2000 rpm for 20 min. The 
supernatant serum was collected in another Eppendorf tube and is 
checked for turbidity. If turbidity is present, then again it is subjected 
for recentrifugation at 2000 rpm for 10 min. The clear serum was used 
for the estimation of various biochemical parameters - urea, BUN, 
creatinine, TC, TP, and uric acid [6].
Euthanasia and liver homogenate preparation
All experimental animals were sacrificed by overdose of thiopental 
sodium anesthesia (150 mg/kg b.w i.p) as per CPCEA norms. 
Immediately, only the liver was removed and washed with ice-cold 
physiological saline. The liver was done into small pieces and was 
homogenized using RMS tissue homogenizer in 0.1M tris-HCl buffer 
pH 7.4 to give a 10% homogenate. This homogenate was used for the 
antioxidant parameters estimation (malondialdehyde [MDA] and 
GSH) [9]. The portion of the liver was treated for the histopathological 
observation.
Estimation of serum creatinine
Serum creatinine level was estimated using Erba Diagnostic kit. The 
absorbance of standard and test was read against blank at 505 nm or 
505–670 nm using autoanalyzer and the concentration was noted down 
which appeared on the autoanalyzer.
Estimation of serum cholesterol
For the estimation of serum cholesterol, Erba Diagnostic kit was utilized. 
Estimation was performed by end point method. The absorbance of 
standard and test was read against blank at 505 nm or 505–670 nm 
using autoanalyzer and also the concentration which appears in 
autoanalyzer was noted down.
Estimation of serum urea and BUN
The estimation of serum urea was estimated utilizing Erba Diagnostic 
kit. The estimation was performed using fixed-time method. The 
absorbance of the test was read at 340 nm and the concentration 
was noted down which appeared on the semi autoanalyzer. BUN was 
calculated by serum urea ×0.467.
Estimation of serum TP
The estimation of serum TP was estimated using Erba Diagnostic kit. 
The estimation was performed using end point method. The absorbance 
of the test was read at 546 nm and the concentration was noted down 
which appeared on the autoanalyzer.
Estimation of uric acid
The estimation of serum uric acid was estimated using Erba Diagnostic 
kit. The estimation was performed using end point method. The 
absorbance of the test was read at 546 nm and the concentration was 
noted down which appeared on the semi autoanalyzer.
Estimation of lipid peroxidation
The assay mixture method was followed according to Ohkawa et al. 
The reaction mixture contained 0.2 ml of 8.1% sodium dodecyl sulfate, 
1.5 ml of 20% acetic acid solution was adjusted to pH 3.5 by sodium 
hydroxide, and 1.5 ml of 0.8% aqueous solution of thiobarbituric acid 
was added to 0.2 ml of post-mitochondrial supernatant (10% w/v) 
of homogenate. The mixture was brought up to 4 ml with distilled 
water and heated at 95°C for 60 min, after cooling with tap water, 
1 ml distilled water, and 5 ml of the mixture of n-butanol and pyridine 
(15:1 v/v) was added and centrifuged. The organic layer was removed 
and its absorbance was measured at 532 nm against blank using semi 
autoanalyzer.
Estimation of GSH
The assay mixture was followed according to the Ellman’s method. To 
0.1 ml of tissue homogenate, 2.4 ml of 0.002 M EDTA solution was added 
and kept on ice bath for 10 min. Then, 2 ml of distilled water and 0.5 ml 
of 50% trichloroacetic acid were added. The mixture was maintained 
at ice bath for 10–15 min and then centrifuged at 3000 rpm for 15 min. 
1 ml of supernatant was taken and 2 ml of tris-HCl buffer was added 
followed by 0.05 ml of DTNB solution (Ellman’s reagent). A yellow color 
was developed read immediately at absorbance of 412 nm against blank 
using semi autoanalyzer. GSH content was calculated using extension 




Absorption at 412 nmCalculation :GSH 
Extinction coefficient TP  total volume
Statistical analysis
Values reported were expressed as mean ± standard deviation. 
The statistical analysis was carried out using one-way analysis of 
variance, followed by Bonferroni method of statistics for comparison 
of selected pairs to compare the treatment groups with the control 
groups. Calculations were carried out using GraphPad Prism statistical 
program (version: 5.03). With all analyses, an associated p<0.0001 was 
considered statistically significant.
RESULTS
Effect on body weight
In Table 1 the alloxan-induced DM rats have shown remarkable 
decrease in the body weight on the 20th day when compared to normal 
vehicle group rats (Group I). Groups III and IV DM rats treated with 
glibenclamide and MLEKP showed an increase in the body weight level 
when compared to Group II DM control rats. The efficacy of MLEKP in 
increasing the body weight is more than the standard.
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Effect on blood glucose
In Table 2 the alloxan-induced DM rats (Group II) have shown significant 
increase in the blood glucose level on the 20th day when compared to 
normal vehicle group rats (Group I). Groups III and IV DM rats treated 
with glibenclamide and MLEKP have shown significant decrease in the 
blood glucose levels when compared to Group II DM control rats.
Serum urea, uric acid, and BUN
 The alloxan-induced DM rats (Group II) in Table3 have shown 
significant increase in the serum urea, uric acid, and BUN levels on 
the 20th day when compared to normal vehicle group rats (Group I). 
Groups III and IV DM rats treated with glibenclamide and MLEKP have 
shown significant decrease in the serum urea, uric acid, and BUN levels 
when compared to Group II DM control rats.
Serum TC, creatinine, and TP
In Table 4 the alloxan-induced DM rats (Group II) have shown notable 
increase in the serum TC, creatinine, and TP levels on the 20th day when 
compared to normal vehicle group rats (Group I). Groups III and IV DM 
rats treated with glibenclamide and MLEKP have shown significant 
decrease in the serum TC, creatinine, and TP levels when compared to 
Group II DM control rats.
Tissue (liver) parameters - lipid peroxidation (MDA) and reduced 
GSH
In Table 5 the MDA and GSH values have shown that the alloxan-induced 
DM rats (Group II) have shown significant rise in the liver tissue lipid 
peroxidation and decrease in the reduced GSH levels on the 20th day 
when compared to normal vehicle group rats (Group I). Groups III and IV 
DM rats treated with glibenclamide and MLEKP have shown significant 
decrease in the liver tissue lipid peroxidation levels and increase in the 
reduced GSH levels when compared to Group II DM control rats.
Histopathological studies
Normal vehicle group rats liver histology illustrated in Fig. 1 and 
expressed prominent nuclei of the hepatocytes, central artery, 
sinusoids, Kupffer cells, canaliculi, hepatic ductules, etc.
Inflammatory cells infiltration was not observed. Alloxan administrated rats 
in Fig. 2 resulted in the disruption of hepatocytes, steatosis to steatohepatitis, 
and liver fibrosis; morphological, ultrastructural lesions were observed in 
the lobules of the liver. DM rats administered with glibenclamide (Group III) 
and MLEKP (Group IV) in Figs. 3 and 4 have shown significant protection 
to the hepatocyte and other structural components of the liver. Only mild 
disruptions were observed both in Groups III and IV rats.
Table 1: Effects on body weight in normal, DM, and treated DM rats
Gp n=6 Gp name Initial weight (g ) Weight on the 20th day Percentage change
I Normal control 182.83±6.50 205±60.33 12.12% increase
II DM 174.8±14.90 167.33±14.50 4.27% decrease
III DM+Glibc 195.16±7.14 207.50±10.30 6.32% increase
IV DM+MLEKP 166.66±9.90 190.16±8.50 14.1% increase
MLEKP: Methanolic leaf extract of Kalanchoe pinnata, Glibc: Glibenclamide, Gp: Group
Table 2: Effects on blood glucose in normal, DM, and treated DM rats
Gp n=6 Gp name Initial blood glucose (g/dl) Final blood glucose (g/dl)
I Normal control 128.33±10.08 137.5±7.33
II DM 306.16±48.2**a 331.66±44.3***a
III DM+Glibc 353.66±35.9 174.33±15.4***b
IV DM+MLEKP 328±33.70 180.16±18.06**b
Table 3: Effects on serum urea, uric acid, and BUN in normal, DM, and treated DM rats
Gp n=6 Gp name Urea (mg/dl) Uric acid (mg/dl) BUN (mg/dl)
I Normal control 38.81±4.80 1.38±0.09 18.13±2.23
II DM 60.35±2.30***a 2.23±0.008***a 28.17±1.07***a
III DM+Glibc 35.54±3.13***b 1.54±0.10***b 16.59±1.46***b
IV DM+MLEKP 39.33±3.84***b 1.53±0.09***b 18.36±1.79***b
Table 4: Effects on serum total cholesterol, creatinine, and total protein in normal, DM, and treated DM rats
Gp n=6 Gp name TC (mg/dl) Creatinine (mg/dl) TP (mg/dl)
I Normal control 179.64±11.44 0.50±0.001 0.50±0.001
II DM 242.81±31.42**a 0.62±0.04*a 2.80±0.10***a
III DM+Glibc 201.91±25.81**b 0.39±0.06**b 2.37±0.03**b
IV DM+MLEKP 179.77±5.06***b 0.50±0.05*b 2.36±0.06***b
TC: Total cholesterol, TP: Total protein
Fig. 1: Normal liver
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DISCUSSION
DM is characterized by hyperglycemia and abnormal increase in the lipid 
profile including TC, triglycerides, low-density lipoproteins (LDL), very 
LDL, and other lipoproteins. The alloxan-induced DM rats were used in 
the present study. DM rats (Group II) have shown significant decrease in 
the body weight when compared to the normal vehicle group (Group I). 
Alloxan-induced DM caused a significant loss in body weight while 
treatment with MLEKP restored the body weight. This effect of MLEKP 
may be due to its prevention effects on glycogenolysis, lipolysis, and 
gluconeogenesis. This leads to the prevention of muscle wasting and loss 
of tissue protein. These results confirm the efficacy of MLEKP in restoring 
body weight in alloxan-induced DM rats. Previous studies suggested 
that hyperglycemia and hyperlipidemia are the common characteristics 
of alloxan-induced DM in experiments rats [13]. Hyperglycemia gives 
rise to many complications in DM. The blood glucose levels in DM rats 
treated with MLEKP decrease significantly at the end of the study period 
when compared to normal rats, while DM control rats showed significant 
increase in blood sugar levels. Alloxan causes diabetes in rats by damaging 
the insulin-secreting beta-cells of the pancreas, leading to hyperglycemia 
[7]. The important phytoconstituents (including flavonoids) present in 
MLEKP are believed to lower the blood glucose level by promoting the 
glucose into the tissue cells, by stimulating the enzymes needed for the 
glycogenesis, and by increasing the expression of insulin receptors.
Oral administration of MLEKP produced significant beneficial effects 
in the lipid profile (serum TC and triglyceride) of the alloxan-induced 
DM rats significantly reducing serum cholesterol and triglyceride levels. 
These results suggest that MLEKP might be considered as a substitute 
for drugs to reduce complications associated with DM.
An increase in blood creatinine may indicate kidney dysfunction. 
The alloxan-induced DM rats have showed elevated levels of serum 
creatinine. MLEKP administered rats have shown significant decreased 
levels, suggesting protection to the kidney in alloxan-induced DM rats.
Alloxan reacts with two thio (SH)  groups in the sugar binding site 
of glucokinase resulting in the formation of the disulfide bond and 
inactivation of the enzyme. As a result of alloxan reduction, dialuric 
acid is formed which is then reoxidized back to alloxan establishing a 
redox cycle for the generation of ROS and superoxide radicals [8]. The 
alloxan-induced DM rats have shown significant increase in the lipid 
peroxidation (MDA) due to oxidative stress. DM rats treated with MLEKP 
have shown significant decrease in the level of lipid peroxidation, 
indicating the effect of MLEKP in preventing the oxidative stress caused 
by alloxan in rats. The alloxan-induced DM rats have shown significant 
increase in the GSH due to oxidative stress. DM rats treated with MLEKP 
have shown significant increase in GSH level, indicating the effect of 
MLEKP in preventing the oxidative stress caused by alloxan in rats.
DM rats administered with glibenclamide (Group III) and MLEKP 
(Group IV) (Figs. 3 and 4) have shown significant protection to the 
hepatocyte and other structural components of the liver. Only mild 
disruptions were observed both in Groups III and IV rats.
CONCLUSION
We conclude that the methanolic extract of the leaf of K. pinnata has potent 
antioxidant and antidiabetic effect in alloxan-induced diabetic mellitus 
rats. The flavonoid and tannins isolated from other antidiabetic medicinal 
plants have been found to stimulate secretion of insulin-like effect. Further, 
pharmacological investigations are needed to elucidate the mechanism of 
the observed antidiabetic activity. The present investigation has also opened 
avenues for further research, especially with reference to the development of 
potent formulation for DM from methanolic extract of the leaf of K. pinnata.
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Fig. 2: Diseased liver
Fig. 3: Glibenclamide-treated liver 
Fig. 4: MLEKP-treated liver
Table 5: Effects on MDA and GSH in normal, DM, and treated DM 
rats




I Normal control 630.33±6.70 28. 15±0.06
II DM 1232.89±8.44***a 11±0.04***a
III DM+Glibc 963.66±14.23***b 19.31±0.08***b
IV DM+MLEKP 94.3±7.90***b 38.92±0.12***
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